AbCellera Biologics :
ABCL
ABCL
Stock Data
$4.24
$0.40 (8.62%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
AbCellera Biologics Inc. is a pioneer in the field of antibody drug discovery, leveraging a unique engine that sifts through natural immune responses to find promising antibodies for development. With a portfolio of discovery programs at various stages and strategic collaborations with industry giants like Eli Lilly, as well as partnerships focused on GPCR target antibodies, AbCellera stands out in biotech. Founded in 2012 and based in Vancouver, Canada, the company is at the forefront of developing innovative treatments.
